{"parse":{"title":"Pledge to Africa Act","pageid":5388932,"revid":835155856,"text":{"*":"<div class=\"mw-parser-output\"><p>The <i><b>Jean Chr\u00e9tien Pledge to Africa Act</b></i>, full title <i><b>An Act to amend the Patent Act and the Food and Drugs Act (The Jean Chr\u00e9tien Pledge to Africa)</b></i>, (the <i>Act</i>) a key piece of legislation implementing <a href=\"/wiki/Canada%27s_Access_to_Medicines_Regime\" title=\"Canada&#39;s Access to Medicines Regime\">Canada's Access to Medicines Regime</a>, was a bill introduced as C-9 in the third session of the <a href=\"/wiki/37th_Canadian_Parliament\" title=\"37th Canadian Parliament\">37th Canadian Parliament</a>.  It represented the first implementation of the <a href=\"/wiki/TRIPS\" class=\"mw-redirect\" title=\"TRIPS\">TRIPS</a> flexibilities declared in the August 30, 2003, General Council decision. Enacted in May 2004, it allows Canada to enact <a href=\"/wiki/Compulsory_license\" title=\"Compulsory license\">compulsory licenses</a> to export <a href=\"/wiki/Essential_medicines\" title=\"Essential medicines\">essential medicines</a> to countries without the capacity to manufacture their own. Other countries that have since enacted similar legislation include <a href=\"/wiki/Norway\" title=\"Norway\">Norway</a> and <a href=\"/wiki/India\" title=\"India\">India</a>.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Purpose\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Purpose</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Criticisms\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Criticisms</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#References_and_notes\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">References and notes</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#See_also\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#External_links\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Purpose\">Purpose</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pledge_to_Africa_Act&amp;action=edit&amp;section=1\" title=\"Edit section: Purpose\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The purpose of the <i>Act</i> is to improve access to drugs for developing countries that lack the resources to manufacture the drugs and cannot afford to buy them at the usual market cost.<sup id=\"cite_ref-Stephen_Lewis_Foundation_Newsletter_1-0\" class=\"reference\"><a href=\"#cite_note-Stephen_Lewis_Foundation_Newsletter-1\">&#91;1&#93;</a></sup> The drugs that fight these diseases are expensive to create and manufacture and thus are usually unaffordable for those who need them the most.<sup id=\"cite_ref-Matthew_Rimmer._The_Jean_Chr\u00e9tien_Pledge_to_Africa_Act:_Patent_Law_and_Humanitarian_Aid_Expert_Opinion_on_Therapeutic_Patents_Jul._2005:889-909_2-0\" class=\"reference\"><a href=\"#cite_note-Matthew_Rimmer._The_Jean_Chr\u00e9tien_Pledge_to_Africa_Act:_Patent_Law_and_Humanitarian_Aid_Expert_Opinion_on_Therapeutic_Patents_Jul._2005:889-909-2\">&#91;2&#93;</a></sup>\n</p><p>The <i>Pledge to Africa Act</i> allows for the <a href=\"/wiki/Patent\" title=\"Patent\">patents</a> on these drugs to be overridden so that manufacturers can produce generic versions of the drug to sell in underdeveloped countries.<sup id=\"cite_ref-Stephen_Lewis_Foundation_Newsletter_1-1\" class=\"reference\"><a href=\"#cite_note-Stephen_Lewis_Foundation_Newsletter-1\">&#91;1&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Criticisms\">Criticisms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pledge_to_Africa_Act&amp;action=edit&amp;section=2\" title=\"Edit section: Criticisms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Some questions have been raised concerning the <i>Act'</i>s efficacy, or lack thereof, at increasing the availability of pharmaceuticals in poor nations.<sup id=\"cite_ref-Is_Canada_Delivering_on_its_Pledge_to_Aid_Africa?_3-0\" class=\"reference\"><a href=\"#cite_note-Is_Canada_Delivering_on_its_Pledge_to_Aid_Africa?-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-Access_to_Drugs_Initiative_4-0\" class=\"reference\"><a href=\"#cite_note-Access_to_Drugs_Initiative-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-The_Jean_Chr\u00e9tien_Pledge_to_Africa_Act_and_its_Impact_on_Improving_Access_to_HIV/AIDS_Treatment_in_Developing_Countries_5-0\" class=\"reference\"><a href=\"#cite_note-The_Jean_Chr\u00e9tien_Pledge_to_Africa_Act_and_its_Impact_on_Improving_Access_to_HIV/AIDS_Treatment_in_Developing_Countries-5\">&#91;5&#93;</a></sup> It took a full year from the time the bill was introduced to the time that it came into effect. Since the <i>Act</i> came into effect in 2005, only one drug has been manufactured and exported under the act.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2010)\">citation needed</span></a></i>&#93;</sup>  It has been suggested that this is because restrictions incorporated into the <i>Act</i> make it too difficult for generic drug companies to get permission to produce a generic and to export it to countries in need.  The process for obtaining <a href=\"/wiki/Patent\" title=\"Patent\">patent</a> exemptions under the <i>Act</i> is quite costly, and the exemption must be renewed every two years.  As such, it may not be economically viable for generic drug makers to apply for an exemption, or even if it is, the expense and mandated frequent renewals may tend to discourage generic makers from applying.<sup id=\"cite_ref-Is_Canada_Delivering_on_its_Pledge_to_Aid_Africa?_3-1\" class=\"reference\"><a href=\"#cite_note-Is_Canada_Delivering_on_its_Pledge_to_Aid_Africa?-3\">&#91;3&#93;</a></sup>  Additionally, exporting pharmaceuticals under the <i>Act</i> to countries that are not part of the <a href=\"/wiki/World_Trade_Organisation\" class=\"mw-redirect\" title=\"World Trade Organisation\">World Trade Organisation</a>'s <a href=\"/wiki/Agreement_on_Trade-Related_Aspects_of_Intellectual_Property_Rights\" class=\"mw-redirect\" title=\"Agreement on Trade-Related Aspects of Intellectual Property Rights\">TRIPS agreement</a> is made more difficult by further restrictions.<sup id=\"cite_ref-Is_Canada_Delivering_on_its_Pledge_to_Aid_Africa?_3-2\" class=\"reference\"><a href=\"#cite_note-Is_Canada_Delivering_on_its_Pledge_to_Aid_Africa?-3\">&#91;3&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References_and_notes\">References and notes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pledge_to_Africa_Act&amp;action=edit&amp;section=3\" title=\"Edit section: References and notes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-Stephen_Lewis_Foundation_Newsletter-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Stephen_Lewis_Foundation_Newsletter_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Stephen_Lewis_Foundation_Newsletter_1-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.stephenlewisfoundation.org/documents/SLFNewsletter2005.pdf\">http://www.stephenlewisfoundation.org/documents/SLFNewsletter2005.pdf</a></span>\n</li>\n<li id=\"cite_note-Matthew_Rimmer._The_Jean_Chr\u00e9tien_Pledge_to_Africa_Act:_Patent_Law_and_Humanitarian_Aid_Expert_Opinion_on_Therapeutic_Patents_Jul._2005:889-909-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Matthew_Rimmer._The_Jean_Chr\u00e9tien_Pledge_to_Africa_Act:_Patent_Law_and_Humanitarian_Aid_Expert_Opinion_on_Therapeutic_Patents_Jul._2005:889-909_2-0\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://works.bepress.com/matthew_rimmer/12/\">The Jean Chr\u00e9tien Pledge to Africa Act: Patent Law and Humanitarian Aid</a></span>\n</li>\n<li id=\"cite_note-Is_Canada_Delivering_on_its_Pledge_to_Aid_Africa?-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Is_Canada_Delivering_on_its_Pledge_to_Aid_Africa?_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Is_Canada_Delivering_on_its_Pledge_to_Aid_Africa?_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Is_Canada_Delivering_on_its_Pledge_to_Aid_Africa?_3-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.yorku.ca/dapina/lw2970/ip/?p=188\">ipilogue&#160;\u00bb Blog Archive&#160;\u00bb Is Canada Delivering on its Pledge to Aid Africa?</a></span>\n</li>\n<li id=\"cite_note-Access_to_Drugs_Initiative-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Access_to_Drugs_Initiative_4-0\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.law.utoronto.ca/accesstodrugs/History.htm\">Access to Drugs Initiative - History</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20080803105114/http://www.law.utoronto.ca/accesstodrugs/History.htm\">Archived</a> 2008-08-03 at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-The_Jean_Chr\u00e9tien_Pledge_to_Africa_Act_and_its_Impact_on_Improving_Access_to_HIV/AIDS_Treatment_in_Developing_Countries-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-The_Jean_Chr\u00e9tien_Pledge_to_Africa_Act_and_its_Impact_on_Improving_Access_to_HIV/AIDS_Treatment_in_Developing_Countries_5-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20071213111739/http://icad-cisd.com/pdf/publications/ACCESS_FSandCaseStudies_FINALAug4_06_EN.pdf\">\"Archived copy\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.icad-cisd.com/pdf/publications/ACCESS_FSandCaseStudies_FINALAug4_06_EN.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 2007-12-13<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-07-25</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.icad-cisd.com%2Fpdf%2Fpublications%2FACCESS_FSandCaseStudies_FINALAug4_06_EN.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APledge+to+Africa+Act\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pledge_to_Africa_Act&amp;action=edit&amp;section=4\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Canada%27s_Access_to_Medicines_Regime\" title=\"Canada&#39;s Access to Medicines Regime\">Canada's Access to Medicines Regime</a></li>\n<li><a href=\"/wiki/Patent_Act_(Canada)\" title=\"Patent Act (Canada)\">Patent Act</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pledge_to_Africa_Act&amp;action=edit&amp;section=5\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external free\" href=\"http://www2.parl.gc.ca/HousePublications/Publication.aspx?Docid=2331620&amp;file=4\">http://www2.parl.gc.ca/HousePublications/Publication.aspx?Docid=2331620&amp;file=4</a> \u2014 the full text of the Bill</li>\n<li><a rel=\"nofollow\" class=\"external free\" href=\"http://www.camr-rcam.gc.ca/\">http://www.camr-rcam.gc.ca/</a> \u2014 the Canadian government site for the Regime</li>\n<li><a rel=\"nofollow\" class=\"external free\" href=\"http://www.aidslaw.ca/camr/\">http://www.aidslaw.ca/camr/</a></li>\n<li><a rel=\"nofollow\" class=\"external free\" href=\"https://web.archive.org/web/20070209020526/http://www.law.utoronto.ca/accesstodrugs/\">https://web.archive.org/web/20070209020526/http://www.law.utoronto.ca/accesstodrugs/</a></li>\n<li><a rel=\"nofollow\" class=\"external free\" href=\"http://www.cptech.org/ip/health/c/canada/c9.html\">http://www.cptech.org/ip/health/c/canada/c9.html</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1270\nCached time: 20180909215044\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.096 seconds\nReal time usage: 0.135 seconds\nPreprocessor visited node count: 322/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 4241/2097152 bytes\nTemplate argument size: 554/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 5386/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.042/10.000 seconds\nLua memory usage: 1.95 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  112.826      1 -total\n 49.46%   55.801      1 Template:Citation_needed\n 49.36%   55.689      1 Template:Reflist\n 35.57%   40.128      1 Template:Fix\n 28.33%   31.964      1 Template:Cite_web\n 24.14%   27.240      2 Template:Category_handler\n  8.62%    9.723      1 Template:Delink\n  7.79%    8.784      1 Template:Webarchive\n  3.15%    3.549      1 Template:Main_other\n  2.68%    3.022      1 Template:Fix/category\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:5388932-0!canonical and timestamp 20180909215044 and revision id 835155856\n -->\n</div>"},"langlinks":[{"lang":"it","url":"https://it.wikipedia.org/wiki/Pledge_to_Africa_Act","langname":"Italian","autonym":"italiano","*":"Pledge to Africa Act"}],"categories":[{"sortkey":"","hidden":"","*":"Webarchive_template_wayback_links"},{"sortkey":"Pledge To Africa Act","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"Pledge To Africa Act","hidden":"","*":"Articles_with_unsourced_statements_from_March_2010"},{"sortkey":"Pledge To Africa Act","*":"Canadian_federal_legislation"},{"sortkey":"Pledge To Africa Act","*":"Foreign_relations_of_Canada"},{"sortkey":"Pledge To Africa Act","*":"Canadian_patent_law"},{"sortkey":"Pledge To Africa Act","*":"Pharmaceuticals_policy"},{"sortkey":"Pledge To Africa Act","*":"2004_in_Canadian_law"},{"sortkey":"Pledge To Africa Act","*":"2004_in_international_relations"},{"sortkey":"Pledge To Africa Act","*":"Health_in_Africa"},{"sortkey":"Pledge To Africa Act","*":"2004_in_Africa"},{"sortkey":"Pledge To Africa Act","*":"37th_Canadian_Parliament"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from March 2010"},{"ns":0,"exists":"","*":"37th Canadian Parliament"},{"ns":0,"exists":"","*":"Agreement on Trade-Related Aspects of Intellectual Property Rights"},{"ns":0,"exists":"","*":"Canada's Access to Medicines Regime"},{"ns":0,"exists":"","*":"Compulsory license"},{"ns":0,"exists":"","*":"Essential medicines"},{"ns":0,"exists":"","*":"India"},{"ns":0,"exists":"","*":"Norway"},{"ns":0,"exists":"","*":"Patent"},{"ns":0,"exists":"","*":"Patent Act (Canada)"},{"ns":0,"exists":"","*":"TRIPS"},{"ns":0,"exists":"","*":"Wayback Machine"},{"ns":0,"exists":"","*":"World Trade Organisation"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"}],"templates":[{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Webarchive"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Webarchive"},{"ns":828,"exists":"","*":"Module:Webarchive/data"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":[],"externallinks":["http://works.bepress.com/matthew_rimmer/12/","http://www.yorku.ca/dapina/lw2970/ip/?p=188","http://www.law.utoronto.ca/accesstodrugs/History.htm","https://web.archive.org/web/20080803105114/http://www.law.utoronto.ca/accesstodrugs/History.htm","https://web.archive.org/web/20071213111739/http://icad-cisd.com/pdf/publications/ACCESS_FSandCaseStudies_FINALAug4_06_EN.pdf","http://www.icad-cisd.com/pdf/publications/ACCESS_FSandCaseStudies_FINALAug4_06_EN.pdf","http://www.stephenlewisfoundation.org/documents/SLFNewsletter2005.pdf","http://www2.parl.gc.ca/HousePublications/Publication.aspx?Docid=2331620&file=4","http://www.camr-rcam.gc.ca/","http://www.aidslaw.ca/camr/","https://web.archive.org/web/20070209020526/http://www.law.utoronto.ca/accesstodrugs/","http://www.cptech.org/ip/health/c/canada/c9.html"],"sections":[{"toclevel":1,"level":"2","line":"Purpose","number":"1","index":"1","fromtitle":"Pledge_to_Africa_Act","byteoffset":740,"anchor":"Purpose"},{"toclevel":1,"level":"2","line":"Criticisms","number":"2","index":"2","fromtitle":"Pledge_to_Africa_Act","byteoffset":1754,"anchor":"Criticisms"},{"toclevel":1,"level":"2","line":"References and notes","number":"3","index":"3","fromtitle":"Pledge_to_Africa_Act","byteoffset":4089,"anchor":"References_and_notes"},{"toclevel":1,"level":"2","line":"See also","number":"4","index":"4","fromtitle":"Pledge_to_Africa_Act","byteoffset":4322,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"External links","number":"5","index":"5","fromtitle":"Pledge_to_Africa_Act","byteoffset":4413,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Pledge to Africa Act","iwlinks":[],"properties":[{"name":"defaultsort","*":"Pledge To Africa Act"},{"name":"wikibase_item","*":"Q3906622"}]}}